Home
/ Agilent
/ Financials & Metrics

Agilent (A) stock price, revenue, and financials

Agilent market cap is $36.1 b, and annual revenue was $6.32 b in FY 2021

View Company

+5.75(+4.82%)

$36.1 B

A Mkt cap, 13-May-2022

$1.7 B

Agilent Revenue Q1, 2022

Agilent Gross profit (Q1, 2022)910 M

Agilent Gross profit margin (Q1, 2022), %54.4%

Agilent Net income (Q1, 2022)283 M

Agilent EBIT (Q1, 2022)376 M

Agilent Cash, 31-Jan-20221.1 B

Agilent EV37.7 B

Agilent Revenue

Agilent revenue was $6.32 b in FY, 2021 which is a 18.4% year over year increase from the previous period.

Embed Graph

Agilent Revenue Breakdown

Embed Graph

Agilent revenue breakdown by business segment: 44.7% from Life Sciences and Applied Markets, 34.8% from Agilent CrossLab and 20.5% from Diagnostics and Genomics

Agilent revenue breakdown by geographic segment: 26.7% from Europe, 35.2% from Asia Pacific and 38.0% from Americas

Annual

USD	FY, 2019	FY, 2020	FY, 2021
Revenue	5.2b	5.3b	6.3b
Revenue growth, %	5%	3%	18%
Cost of goods sold	2.4b	2.5b	2.9b
Gross profit	2.8b	2.8b	3.4b
Gross profit Margin, %	54%	53%	54%
R&D expense	404.0m	495.0m	441.0m
General and administrative expense	1.5b	1.5b	1.6b
Operating expense total	1.9b	2.0b	2.1b
EBIT	941.0m	846.0m	1.3b
EBIT margin, %	18%	16%	21%
Interest expense	74.0m	78.0m	81.0m
Interest income	36.0m	8.0m	2.0m
Pre tax profit	919.0m	842.0m	1.4b
Income tax expense	(152.0m)	123.0m	150.0m
Net Income	1.1b	719.0m	1.2b
EPS	3.4	2.3	3.9

Quarterly

USD	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021	Q1, 2022
Revenue	1.3b	1.2b	1.3b	1.4b	1.2b	1.3b	1.5b	1.5b	1.6b	1.7b
Cost of goods sold	577.0m	569.0m	582.0m	634.0m	581.0m	592.0m	710.0m	708.0m	734.0m	764.0m
Gross profit	707.0m	669.0m	692.0m	723.0m	657.0m	669.0m	838.0m	817.0m	852.0m	910.0m
Gross profit Margin, %	55%	54%	54%	53%	53%	53%	54%	54%	54%	54%
R&D expense	102.0m	99.0m	101.0m	104.0m	197.0m	92.0m	103.0m	109.0m	113.0m	117.0m
General and administrative expense	355.0m	354.0m	366.0m	404.0m	358.0m	347.0m	407.0m	420.0m	403.0m	417.0m
Operating expense total	457.0m	453.0m	467.0m	508.0m	555.0m	439.0m	510.0m	529.0m	516.0m	534.0m
EBIT	250.0m	216.0m	225.0m	215.0m	102.0m	230.0m	328.0m	288.0m	336.0m	376.0m
EBIT margin, %	19%	17%	18%	16%	8%	18%	21%	19%	21%	22%
Interest expense	18.0m	17.0m	18.0m	20.0m	20.0m	19.0m	19.0m	20.0m	21.0m	21.0m
Interest income	10.0m	10.0m	10.0m	3.0m	3.0m	1.0m		1.0m		1.0m
Pre tax profit	248.0m	218.0m	222.0m	219.0m	121.0m	219.0m	312.0m	273.0m	327.0m	319.0m
Income tax expense	(256.0m)	36.0m	31.0m	22.0m	20.0m	20.0m	24.0m	57.0m	63.0m	36.0m
Net Income	504.0m	182.0m	191.0m	197.0m	101.0m	199.0m	288.0m	216.0m	264.0m	283.0m
EPS	1.6	0.6	0.6	0.6	0.3	0.6	0.9	0.7	0.9	0.9

Annual

USD	FY, 2019	FY, 2020	FY, 2021
Cash	1.4b	1.4b	1.5b
Accounts Receivable	930.0m	1.0b	1.2b
Inventories	679.0m	720.0m	830.0m
Current Assets	3.2b	3.4b	3.8b
PP&E	850.0m	845.0m	945.0m
Goodwill	3.6b	3.6b	4.0b
Total Assets	9.5b	9.6b	10.7b
Accounts Payable	354.0m	354.0m	446.0m
Short-term debt	616.0m	75.0m
Current Liabilities	2.1b	1.5b	1.7b
Long-term debt	1.8b	2.3b	2.7b
Total Debt	2.4b	2.4b	2.7b
Total Liabilities	4.7b	4.8b	5.3b
Common Stock	3.0m	3.0m	3.0m
Additional Paid-in Capital	5.3b	5.3b	5.3b
Retained Earnings	(18.0m)	81.0m	348.0m
Total Equity	4.7b	4.9b	5.4b
Debt to Equity Ratio	0.5 x	0.5 x	0.5 x
Debt to Assets Ratio	0.3 x	0.2 x	0.3 x
Financial Leverage	2 x	2 x	2 x

Quarterly

USD	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021	Q1, 2022
Cash	1.2b	1.3b	1.4b	1.3b	1.4b	1.4b	1.1b
Accounts Receivable	966.0m	886.0m	930.0m	1.1b	1.1b	1.1b	1.2b
Inventories	706.0m	750.0m	746.0m	755.0m	791.0m	818.0m	879.0m
Current Assets	3.1b	3.2b	3.2b	3.5b	3.5b	3.6b	3.5b
PP&E	844.0m	836.0m	846.0m	866.0m	884.0m	905.0m	974.0m
Goodwill	3.6b	3.6b	3.6b	3.6b	4.1b	4.0b	4.0b
Total Assets	9.5b	9.5b	9.5b	9.7b	10.4b	10.5b	10.3b
Accounts Payable	329.0m	333.0m	311.0m	398.0m	423.0m	416.0m	475.0m
Short-term debt	675.0m	700.0m	40.0m	314.0m	205.0m	130.0m
Current Liabilities	1.9b	1.9b	1.3b	1.7b	1.8b	1.7b	1.6b
Long-term debt	1.8b	1.8b	2.3b	2.2b	2.7b	2.7b	2.7b
Total Debt	2.5b	2.5b	2.3b	2.5b	2.9b	2.9b	2.7b
Total Liabilities	4.7b	4.7b	4.6b	4.9b	5.6b	5.5b	5.2b
Common Stock	3.0m	3.0m	3.0m	3.0m	3.0m	3.0m	3.0m
Additional Paid-in Capital	5.3b	5.3b	5.3b	5.3b	5.3b	5.3b	5.3b
Retained Earnings	73.0m	15.0m	130.0m	4.0m	(12.0m)	90.0m	159.0m
Total Equity	4.8b	4.8b	5.0b	4.8b	4.8b	4.9b	5.2b
Debt to Equity Ratio	0.5 x	0.5 x	0.5 x	0.5 x	0.6 x	0.6 x	0.5 x
Debt to Assets Ratio	0.3 x	0.3 x	0.2 x	0.3 x	0.3 x	0.3 x	0.3 x
Financial Leverage	2 x	2 x	1.9 x	2 x	2.2 x	2.1 x	2 x

Annual

USD	FY, 2019	FY, 2020	FY, 2021
Net Income	1.1b	719.0m	1.2b
Depreciation and Amortization	238.0m	308.0m	321.0m
Accounts Receivable	(106.0m)	(107.0m)	(128.0m)
Inventories	(36.0m)	(68.0m)	(136.0m)
Accounts Payable	29.0m	2.0m	64.0m
Cash From Operating Activities	1.0b	921.0m	1.5b
Purchases of PP&E	(155.0m)	(119.0m)	(188.0m)
Cash From Investing Activities	(1.6b)	(147.0m)	(749.0m)
Long-term Borrowings	(702.0m)	(1.8b)	(2.1b)
Dividends Paid	(206.0m)	(222.0m)	(236.0m)
Cash From Financing Activities	(299.0m)	(717.0m)	(696.0m)
Net Change in Cash	(866.0m)	59.0m	43.0m
Interest Paid	80.0m	71.0m	76.0m
Income Taxes Paid	159.0m	361.0m	211.0m

Quarterly

USD	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021	Q1, 2022
Net Income	197.0m	298.0m	497.0m	288.0m	504.0m	768.0m	283.0m
Depreciation and Amortization	79.0m	155.0m	232.0m	76.0m	153.0m	237.0m	82.0m
Accounts Receivable	(40.0m)	25.0m	1.0m	(31.0m)	(17.0m)	(69.0m)	(46.0m)
Inventories	(32.0m)	(85.0m)	(86.0m)	(35.0m)	(80.0m)	(115.0m)	(54.0m)
Accounts Payable	(15.0m)	(10.0m)	(35.0m)	43.0m	51.0m	46.0m	37.0m
Cash From Operating Activities	(59.0m)	254.0m	544.0m	238.0m	710.0m	1.0b	255.0m
Purchases of PP&E	(34.0m)	(67.0m)	(92.0m)	(41.0m)	(72.0m)	(126.0m)	(75.0m)
Cash From Investing Activities	(35.0m)	(88.0m)	(120.0m)	(42.0m)	(629.0m)	(690.0m)	(79.0m)
Long-term Borrowings	(376.0m)	(717.0m)	(1.6b)	(651.0m)	(1.5b)	(1.9b)	(240.0m)
Dividends Paid	(56.0m)	(111.0m)	(367.0m)	(59.0m)	(118.0m)	(177.0m)	(63.0m)
Cash From Financing Activities	(61.0m)	(217.0m)	(448.0m)	(316.0m)	(150.0m)	(372.0m)	(546.0m)
Net Change in Cash	(156.0m)	(59.0m)	(24.0m)	(111.0m)	(60.0m)	(12.0m)	(374.0m)
Interest Paid	17.0m	39.0m	53.0m	19.0m	36.0m	53.0m	18.0m
Income Taxes Paid	241.0m	286.0m	325.0m	52.0m	116.0m	164.0m	22.0m

USD	Q1, 2019
Revenue/Employee	83.9k

	FY, 2017	FY, 2018	FY, 2019	FY, 2020	FY, 2021
Customers (Life Sciences and Applied Markets)	26 k	24 k	23.7 k	25.4 k	25.9 k
Customers (Diagnostics and Genomics)	11 k	11 k	11.5 k	10.9 k	11.5 k
Customers (Agilent CrossLab)	49 k	51 k	52.5 k	54.6 k	58.4 k
Facility Space, sq. ft.	5.9 m	6.3 m	6.6 m	6.6 m	6.6 m
Facility Space Owned, sq. ft.	4.3 m	4.4 m	4.5 m	4.6 m	4.6 m
Facility Space Leased, sq. ft.	1.6 m	1.9 m	2.1 m	2 m	2 m

Gender

	FY, 2020	FY, 2019	FY, 2018
Male, percent	20.3%	20.7%	31%
Female (Management), percent	10.1%	9.7%	14.5%
Male (Management), percent	23.2%	23.7%	35.5%
Female (Board), percent	10%	9%
Male (Board), percent	23.3%	24.1%
Female, percent	13%	12.7%	19%